BE899612A - Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives. - Google Patents

Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives.

Info

Publication number
BE899612A
BE899612A BE0/212897A BE212897A BE899612A BE 899612 A BE899612 A BE 899612A BE 0/212897 A BE0/212897 A BE 0/212897A BE 212897 A BE212897 A BE 212897A BE 899612 A BE899612 A BE 899612A
Authority
BE
Belgium
Prior art keywords
derivatives
alpha
vitamin
preparation
intermediate products
Prior art date
Application number
BE0/212897A
Other languages
English (en)
Inventor
H Deluca
H Schnoes
R Sicinski
Y Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BE899612A publication Critical patent/BE899612A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dram (AREA)

Abstract

La présente invention concerne de nouveaux dérivés de la vitamine D2 et plus particulièrement les composés 1-alpha, 25-dihydroxylés de la famille des vitamines D. Elle concerne également un procédé de préparation de ces dérivés et également un procédé pour certains produits intermédiaires utilisés dans ce procédé. La présente invention permet d'obtenir les dérivés 1-alpha, 25-dihydroxyvitamine D2 et leurs acylates (I). Application de ces dérivés comme remplaçants des vitamines D3 ou D2 pour corriger les troubles du métabolisme du calcium et traiter les maladies des os qui y sont associées.
BE0/212897A 1983-05-09 1984-05-09 Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives. BE899612A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09

Publications (1)

Publication Number Publication Date
BE899612A true BE899612A (fr) 1984-08-31

Family

ID=23957917

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212897A BE899612A (fr) 1983-05-09 1984-05-09 Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives.

Country Status (5)

Country Link
JP (1) JPS60501261A (fr)
BE (1) BE899612A (fr)
FR (1) FR2545824B1 (fr)
GB (3) GB2139627B (fr)
IE (1) IE58277B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
JP2608322B2 (ja) * 1988-04-11 1997-05-07 日清製粉株式会社 １α，２５‐ジヒドロキシビタミンＤ▲下２▼類の製造法
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
BR9405735A (pt) * 1993-02-19 1995-12-05 Wisconsin Alumni Res Found Uso de 26,26,26,27,27,27-hexaflúor-1-alfa 25-dihidróxi colecalciferol para o tratamento de distúrbios do metabolismo do cálcio
AU743514B2 (en) 1997-05-16 2002-01-24 Women & Infants Hospital Cyclic ether vitamin D3 compounds, 1alpha (OH) 3-EPI-vitamin D3 compounds and uses thereof
ATE322477T1 (de) * 1997-05-16 2006-04-15 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
AU2001291239A1 (en) * 2000-10-06 2002-04-22 Abbott Laboratories Use of vitamin d2 compounds for alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
NL188286C (nl) * 1978-01-16 1992-05-18 Wisconsin Alumni Res Found Werkwijze voor het bereiden van een 1alfa-hydroxyvitamine d verbinding.
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4264513A (en) * 1979-05-21 1981-04-28 Wisconsin Alumni Research Foundation 1α-hydroxy-25-keto-27-nor-cholecalciferol and processes for preparing same

Also Published As

Publication number Publication date
GB2158442A (en) 1985-11-13
GB2158442B (en) 1987-02-04
IE58277B1 (en) 1993-08-25
GB8507475D0 (en) 1985-05-01
GB2139627A (en) 1984-11-14
JPH0364498B2 (fr) 1991-10-07
IE841149L (en) 1984-11-09
GB8507474D0 (en) 1985-05-01
GB2158443A (en) 1985-11-13
FR2545824A1 (fr) 1984-11-16
FR2545824B1 (fr) 1987-11-20
GB2139627B (en) 1987-02-04
JPS60501261A (ja) 1985-08-08
GB8411794D0 (en) 1984-06-13
GB2158443B (en) 1987-02-04

Similar Documents

Publication Publication Date Title
JPS57167921A (en) Manufacture of epithelial formation composition
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
NO20042151L (no) Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
JPS6485984A (en) Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
BE900979A (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer.
BE899612A (fr) Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
OA07602A (fr) Procédé de préparation de composés de céphem, nouveaux produits ainsi obtenus et compositions pharmaceutiques les renfermant.
AU1486497A (en) 1alpha,24(S)-dihydroxy vitamin D2, its formation and use
DE3766695D1 (de) Bizyklische diphosphonat-verbindungen und arzneimittel.
BE900012A (fr) Nouveau peptide.
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
HUT34174A (en) Process for producing 4-oxo-thiazolidin-2-yliden-acetamide derivatives and pharmaceutical compositions actives for the central nerve systhem,containing them
BE900780A (fr) DERIVES DE LA CHLORO-4-FURO (3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES DERIVES.
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
FR2592043A1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant
BE901879A (fr) Produits analogues de la 1alpha-hydroxyvitamine d2, leur procede de preparation et compositions pharmaceutiques les renfermant.
ATE270882T1 (de) 3r-3'r diastereoisomer von zeaxanthin zur behandlung von der degeneration der macula

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20030531